Voltar
Artigo Acesso aberto Revisado por pares
BIBTEX RIS

Overall survival with cisplatin–gemcitabine and bevacizumab or placebo as first-line therapy for nonsquamous non-small-cell lung cancer: results from a randomised phase III trial (AVAiL)

2010; Elsevier BV; Volume: 21; Issue: 9 Linguagem: Inglês

10.1093/annonc/mdq020

ISSN

1569-8041

Autores

Martin Reck, Joachim von Pawel, Petr Zatloukal, Rodryg Ramlau, V. Gorbounova, Vera Hirsh, N. B. Leighl, J. Mezger, Venice Archer, Norman C. Moore, C. Manegold,

Tópico(s)

Cholangiocarcinoma and Gallbladder Cancer Studies

Referência(s)